Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PAGODA: Randomized Trial of a Proactive Graduated Dose Modification Algorithm for FOLFOX Chemotherapy to Prevent Unplanned Delays

NCT07283939 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT07283939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07283939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PAGODA: Randomized Trial of a Proactive Graduated Dose Modification Algorithm for FOLFOX Chemotherapy to Prevent Unplanned Delays
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Not applicable
Overall status
Recruiting
Start date
February 13, 2026
Completion date
May 2, 2030
Enrollment
420 (estimated)
Sites
368

Conditions

As the registry lists them; a condition with its own page is linked.

ampulla of vater carcinoma, appendix carcinoma, carcinoma of unknown primary with gastrointestinal profile, colon carcinoma, esophageal carcinoma, gastric carcinoma, gastroesophageal junction carcinoma, malignant digestive system neoplasm, rectal carcinoma, small intestinal carcinoma